What are the potential side effects and interactions of milk thistle supplementation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Milk Thistle Side Effects and Interactions

Milk thistle should not be used with certain medications due to significant drug interactions, particularly with drugs metabolized by CYP3A4 and CYP2C9 enzymes, and is contraindicated in patients taking simeprevir and other direct-acting antivirals for hepatitis C treatment. 1

Common Side Effects

  • Milk thistle is generally well-tolerated with minimal adverse effects reported when taken within recommended dosage ranges 2
  • Most common side effects include:
    • Gastrointestinal upset 2
    • Mild laxative effect 2
    • Rare allergic reactions 2

Significant Drug Interactions

Hepatitis C Medications

  • Milk thistle is specifically contraindicated with simeprevir and other direct-acting antivirals (DAAs) for hepatitis C 1
  • Co-administration can lead to significantly altered drug levels of these medications, potentially reducing their effectiveness or increasing toxicity 1

Anticoagulants

  • Documented interaction with warfarin through CYP2C9-mediated mechanism 3
  • Can increase INR (International Normalized Ratio) values, potentially leading to bleeding risk 3
  • First documented in vivo case showed INR increase from 2.64 to 4.12 when milk thistle supplement (200 mg) was added 3

Other Significant Interactions

  • Contraindicated with medications that are substrates of CYP3A4 enzymes, including: 1
    • Anticonvulsants (carbamazepine, oxcarbazepine, phenobarbital, phenytoin)
    • Antibiotics (erythromycin, clarithromycin, telithromycin)
    • Antimycobacterials (rifampin, rifabutin, rifapentine)
    • Antifungals (itraconazole, ketoconazole, posaconazole, fluconazole, voriconazole)
    • Systemically administered dexamethasone
    • Certain HIV medications (cobicistat-based regimens, efavirenz, etravirine, nevirapine, ritonavir)

Special Populations and Considerations

Liver Disease

  • Despite popular use for liver conditions, clinical evidence does not strongly support milk thistle for treatment of chronic liver diseases 4
  • Patients should not delay or replace conventional medical treatment with milk thistle 4
  • Those with liver disease who choose to take milk thistle should continue regular monitoring as directed by their healthcare provider 4

Pregnancy and Breastfeeding

  • Limited safety data available for use during pregnancy or breastfeeding
  • Caution is advised due to lack of sufficient evidence 5

Quality and Standardization Issues

  • Commercial preparations vary significantly in silymarin content (70-80%) with no standardized regulation 4
  • Herbal supplements, including milk thistle, are not regulated by the FDA with the same rigor as prescription medications 4
  • This variation may lead to inconsistent effects or unexpected interactions 4, 5

Monitoring Recommendations

  • Patients taking anticoagulants should have more frequent INR monitoring if starting milk thistle 3
  • Those with liver disease should continue regular liver function monitoring 4
  • Patients should always inform healthcare providers about all supplements they are taking, including milk thistle 4

Long-term Safety

  • Long-term toxicology studies in animals have not shown carcinogenic effects even at high doses 6
  • Some studies suggest potential protective effects against certain cancers, though more research is needed 2, 7

Despite its widespread use and generally favorable safety profile, milk thistle has significant drug interactions that warrant caution, particularly with medications used to treat hepatitis C and anticoagulants. Patients should always disclose milk thistle use to healthcare providers to avoid potentially dangerous interactions.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Advances in the use of milk thistle (Silybum marianum).

Integrative cancer therapies, 2007

Research

CYP2C9-mediated warfarin and milk thistle interaction.

Journal of clinical pharmacy and therapeutics, 2020

Guideline

Milk Thistle Counseling Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.